Browsing: AI
AstraZeneca partners with AI biologics firm Absci, investing $247 million to develop AI-driven antibody therapeutics for cancer treatment.
Hong Kong’s Hospital Authority employs AI to fight superbugs and antibiotic overprescription, starting a pilot program in 2024 to analyze prescription necessity.
Moody’s Analytics unveils a new AI service, Digital Asset Monitor, to predict stablecoin depeggings and assess issuer stability in real-time.